Translational Research in Radiation Oncology
Translational research bridges laboratory discoveries with clinical implementation in radiation oncology. This session focuses on novel radiosensitizers, radioprotectors, genomic predictors of response, and molecular imaging innovations that enhance treatment precision. Preclinical models are advancing understanding of DNA damage pathways, immune-radiation interactions, and resistance mechanisms. Experts will discuss how these discoveries are integrated into early-phase clinical trials, accelerating the development of personalized radiation protocols. Emphasis will be placed on biomarker validation, adaptive treatment strategies, and real-world evidence supporting practice change. Collaborative research networks and multidisciplinary approaches are driving innovation globally. By transforming scientific insights into clinically applicable solutions, translational research ensures continuous advancement in radiation oncology, improving patient survival and safety outcomes worldwide.